The Latest Cardiac and Vascular News
– MCRA’s acquisition of Vorpal Technologies K.K. (Vorpal) bolsters MCRA’s ability to support a domestic market within Asia, expanding MCRA’s overall geographical footprint allowing MCRA to be closer to its client base and their target markets. – Vorpal is the preeminent MedTech consulting firm for Japan and leader in new […]
SHANGHAI, March 10, 2022 /PRNewswire/ — Pulnovo Medical Limited, a globally recognized OTM innovative platform, recently announced the appointment of Ms. Jessie Lian Jia as Chief Executive Officer and Executive Director of the Board. Ms. Lian has more than 20 years of international leadership experience in product commercialization, strategic business development and capital market […]
WALTHAM, Mass., March 9, 2022 /PRNewswire/ — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced that on March 4, 2022, the compensation committee of the company’s board of directors granted ten new non-executive employees options […]
A new post hoc sub-analysis of the landmark REDUCE-IT Study, published in the Journal of the American Heart Association (JAHA), found VASCEPA® significantly reduced the risk of cardiovascular death, strokes, heart attacks, coronary revascularization, and unstable angina by 34% in patients with a history of percutaneous coronary intervention (PCI).(1) Icosapent ethyl […]
GHENT, Belgium, March 10, 2022 (GLOBE NEWSWIRE) — Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), an innovator in the treatment of diuretic-resistant fluid overload in liver disease, malignant ascites and heart failure, announces that in the context of the capital increase that was announced on 7 March 2022 and completed […]
3D Vector ECG Collection Device Slated for FDA 510k Submission in the Fourth Quarter of 2022 SANTA CLARA, Calif.–(BUSINESS WIRE)–HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology for heart attack detection, today announced it has signed a professional services agreement (the “Agreement”) with […]
Dr. Arash Yavari Appointed to Chief Scientific Officer Hugo Fry Appointed to Chief Commercial Officer Komal Joshi Appointed to Chief Financial Officer BOSTON–(BUSINESS WIRE)–Imbria Pharmaceuticals, Inc., a clinical stage, cardio-metabolic company developing novel therapies designed to enhance cellular energetics, today announced the appointments of Arash Yavari, M.B.B.S., DPhil., M.R.C.P., as […]
ST. PAUL, Minn.–(BUSINESS WIRE)–Cardiovascular Systems, Inc. (CSI®) (NASDAQ: CSII), a medical device company developing and commercializing innovative interventional treatment systems for patients with peripheral and coronary artery disease, announced today the start of enrollment in a first in-human trial of the peripheral everolimus drug-coated balloon (DCB) being developed by Chansu […]
Key Radial Surgeon conducts 4 successful percutaneous coronary interventional (PCI) cases at Lakewood Ranch Medical Center with Medical Ingenuities PH Band System. The PH Band System meets SCAI’s Guidelines by achieving patent hemostasis. WHEATON, Ill. , March 9, 2022 /PRNewswire/ — On February 21st, board-certified cardiologist, Dr. Vivek V. Kumar, completed 4 radial cases at […]
– Strong preclinical data shows that C21 reverses vascular remodelling – Proof-of-concept trial in pulmonary arterial hypertension (“PAH”) planned to start late 2022 – Appointment of two new senior clinical advisors in PAH GOTHENBURG, Sweden, March 9, 2022 /PRNewswire/ — Vicore Pharma Holding AB (publ) (“Vicore”), a clinical-stage pharmaceutical company developing medicines targeting […]
